|
|
 Previous Article | Table of Contents | Next Article 
The chromosome 4q21 gene (AF-4/FEL) is widely expressed in normal tissues
and shows breakpoint diversity in t(4;11)(q21;q23) acute leukemia
CS Chen, JM Hilden, J Frestedt, PH Domer, R Moore, SJ Korsmeyer and JH Kersey
Department of Laboratory Medicine/Pathology, University of Minnesota,
Minneapolis 55455.
The chromosomal translocation, t(4;11)(q21;q23), is the most common type of
11q23 chromosomal abnormality, being highly prevalent in infant acute
leukemias and associated with a poor prognosis. The t(4;11) results in the
fusion of an 11q23 gene (MLL, HRX, Htrx-1, or ALL-1) and a 4q21 gene (AF-4
or FEL). To further evaluate the 4q21 gene and its role in t(4;11) acute
leukemia, we have cloned a 38-kb genomic region and mapped exons of the
AF-4 gene. The 4q21 breakpoints in 19 cases of t(4;11) acute leukemia were
analyzed by Southern analysis and pulsed- field gels. Seventeen of the 19
cases had breakpoints on chromosome 4q21 that were scattered in this 38 kb
region. Expression of the AF-4 gene was studied in a total of 28 various
nonhematopoietic, hematopoietic, and t(4;11) leukemic cell lines. The AF-4
gene was expressed in all cell lines as a major and a minor transcript. In
addition to the normal transcripts, two fusion transcripts from the
derivative 11 and derivative 4 chromosomes were identified in all t(4;11)
cell lines except B1, which had only the der(11) transcript. These findings
suggest that the breakpoints on 4q21 cluster over a broader area than do
the breakpoints in the 11q23 gene, and that der(11) encodes the fusion RNA
found consistently in leukemia cells.
Volume 82,
Issue 4,
pp. 1080-1085,
08/15/1993
Copyright © 1993 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
J. Faber, A. V. Krivtsov, M. C. Stubbs, R. Wright, T. N. Davis, M. van den Heuvel-Eibrink, C. M. Zwaan, A. L. Kung, and S. A. Armstrong
HOXA9 is required for survival in human MLL-rearranged acute leukemias
Blood,
March 12, 2009;
113(11):
2375 - 2385.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Isnard, N. Core, P. Naquet, and M. Djabali
Altered lymphoid development in mice deficient for the mAF4 proto-oncogene
Blood,
July 15, 2000;
96(2):
705 - 710.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Q. Li, J. L. Frestedt, and J. H. Kersey
AF4 Encodes a Ubiquitous Protein That in Both Native and MLL-AF4 Fusion Types Localizes to Subnuclear Compartments
Blood,
November 15, 1998;
92(10):
3841 - 3847.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. M. Uckun, K. Herman-Hatten, M.-L. Crotty, M. G. Sensel, H. N. Sather, L. Tuel-Ahlgren, M. B. Sarquis, B. Bostrom, J. B. Nachman, P. G. Steinherz, et al.
Clinical Significance of MLL-AF4 Fusion Transcript Expression in the Absence of a Cytogenetically Detectable t(4;11)(q21;q23) Chromosomal Translocation
Blood,
August 1, 1998;
92(3):
810 - 821.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
